FDG positron emission tomographic imaging of the effect of an intrauterine device
Sosna, J.; Chisin, R.; Klein, M.
Clinical Nuclear Medicine 27(2): 128-129
2002
ISSN/ISBN: 0363-9762 PMID: 11786744 Document Number: 244933
Document emailed within 1 workday
Related Documents
Chang, P.C.; Szemeredi, K.; Grossman, E.; Kopin, I.J.; Goldstein, D.S. 1990: Fate of tritiated 6-fluorodopamine in rats: a false neurotransmitter for positron emission tomographic imaging of sympathetic innervation and function Journal of Pharmacology and Experimental Therapeutics 255(2): 809-817Bakheet, S.; Al-Essa, M.; Patay, Z.; Al-Watban, J.; Dhaunsi, G.; Powe, J.; Ozand, P.T. 1999: Cerebral fluorine-18 fluorodeoxyglucose positron emission tomographic findings in x-linked adrenoleukodystrophy Clinical Nuclear Medicine 24(5): 364-365
Tagawa, K.; Nagata, K.; Shishido, F.; Uemura, K. 1986: Positron emission tomographic localization left-sided unilateral spatial agnosia Rinsho Shinkeigaku 26(3): 300-308
Kjaer, A. 2005: Molecular imaging with positron emission tomography and single photon emission computer tomography. Status and perspectives Ugeskrift for Laeger 167(48): 4549-4552
Yanai, K.; Ryu, J.H.; Watanabe, T.; Iwata, R.; Ido, T.; Asakura, M.; Matsumura, R.; Itoh, M. 1995: Positron emission tomographic study of central histamine H1-receptor occupancy in human subjects treated with epinastine, a second-generation antihistamine Methods and Findings in Experimental and Clinical Pharmacology 17(Suppl): 64-69
Baron, J.C. 1991: In vivo imaging of functional neuroanatomy: positron emission tomography Bulletin de l'Association des Anatomistes 75(229): 85-88
Imahori, Y.; Sasajima, H.; Mineura, K.; Imahori, Y. 2005: Molecular imaging for brain tumor using positron emission tomography Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 9): 250-257
Musholt, T.J.; Musholt, P.B.; Dehdashti, F.; Moley, J.F. 1997: Evaluation of fluorodeoxyglucose-positron emission tomographic scanning and its association with glucose transporter expression in medullary thyroid carcinoma and pheochromocytoma: a clinical and molecular study Surgery 122(6): 1049-60; discussion 1060-1
Kushner, M.J.; Rosenquist, A.; Alavi, A.; Rosen, M.; Dann, R.; Fazekas, F.; Bosley, T.; Greenberg, J.; Reivich, M. 1988: Cerebral metabolism and patterned visual stimulation: a positron emission tomographic study of the human visual cortex Neurology 38(1): 89-95
Shinotoh, H.; Aotsuka, A.; Inoue, O.; Suzuki, K.; Fukuda, H.; Iyo, M.; Yamazaki, T.; Tateno, Y.; Hirayama, K.; Nohara, N. 1991: Imaging of dopamine D1 and D2 receptors by a high resolution positron emission tomography Advances in Experimental Medicine and Biology 287: 249-253
Loken, M.K.; Hawkins, R.A.; Gupta, N.C.; Frick, M.P. 1989: Positron emission tomography (PET): a unique approach for the imaging of in vivo metabolism Nebraska Medical Journal 74(11): 333-339
Hoekstra, C.J.; Hoekstra, O.S.; Teengs, J.P.; Postmus, P.E.; Smit, E.F. 1999: Thoracic actinomycosis imaging with fluorine-18 fluorodeoxyglucose positron emission tomography Clinical Nuclear Medicine 24(7): 529-530
Wiyaporn, K.; Tocharoenchai, C.; Pusuwan, P.; Ekjeen, T.; Leaungwutiwong, S.; Thanyarak, S. 2010: Factors affecting standardized uptake value (SUV) of positron emission tomography (PET) imaging with l8F-FDG Journal of the Medical Association of Thailand 93(1): 108-114
Hargreaves, R. 2002: Imaging substance P receptors (NK1) in the living human brain using positron emission tomography Journal of Clinical Psychiatry 63 Suppl. 11: 18-24
Bolwig, T.G.; Haunsø, S.; Hove, J.D.; Hesse, B.; Højgaard, L.; Jensen, M.; Paulson, O.B.; Svendsen, J.H.; Sørensen, S.S. 1994: Positron emission tomography. a new measurement method for imaging of regional and biochemical parameters Ugeskrift for Laeger 156(43): 6341-6347
Camaggi, V.; Piscaglia, F.; Bolondi, L. 2007: Recent advances in the imaging of hepatocellular carcinoma. From ultrasound to positron emission tomography scan Saudi Medical Journal 28(7): 1007-1014
Melder, R.J.; Brownell, A.L.; Shoup, T.M.; Brownell, G.L.; Jain, R.K. 1993: Imaging of activated natural killer cells in mice by positron emission tomography: preferential uptake in tumors Cancer Research 53(24): 5867-5871
Mautner, V.F.; Brenner, W.; Fünsterer, C.; Hagel, C.; Gawad, K.; Friedrich, R.E. 2007: Clinical relevance of positron emission tomography and magnetic resonance imaging in the progression of internal plexiform neurofibroma in NF1 Anticancer Research 27(4a): 1819-1822
Kling, M.A.; Carson, R.E.; Borg, L.; Zametkin, A.; Matochik, J.A.; Schluger, J.; Herscovitch, P.; Rice, K.C.; Ho, A.; Eckelman, W.C.; Kreek, M.J. 2000: Opioid receptor imaging with positron emission tomography and [(18)F]cyclofoxy in long-term, methadone-treated former heroin addicts Journal of Pharmacology and Experimental Therapeutics 295(3): 1070-1076
Canessa, Jé.A.; Larach, J.A.; Massardo, T.; Parra, J.; Jofré, J.; González, P.; Morales, B.; Humeres, P.; Sierralta, P.; Galaz, R. 2004: Fluorodeoxiglucose F18 positron emission tomography imaging (F18FDG) for the assessment of rising levels of serum CA 19-9 in pancreatic mucinous cystadenocarcinoma. Report of one case Revista Medica de Chile 132(3): 347-352